50shadesofsun.com
Zinbryta use restricted in Europe after a death and four serious liver injuries
The European Medicines Agency (EMA) has restricted the use of multiple sclerosis drug Zinbryta. The agency took action after a patient died from liver injury (fulminant liver failure). The patient …